Market Closed -
Nyse
04:00:02 2024-05-03 pm EDT
|
5-day change
|
1st Jan Change
|
22.13
USD
|
-14.06%
|
|
-14.92%
|
-26.13%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
557.1
|
560.3
|
1,329
|
1,048
|
807.5
|
593.4
|
-
|
Enterprise Value (EV)
1 |
847.1
|
824.7
|
1,449
|
1,132
|
807.5
|
800.4
|
593.4
|
P/E ratio
|
14
x
|
12.2
x
|
9.82
x
|
6.42
x
|
15.4
x
|
20.3
x
|
5.38
x
|
Yield
|
-
|
-
|
-
|
1.47%
|
-
|
2.89%
|
-
|
Capitalization / Revenue
|
0.43
x
|
0.48
x
|
0.79
x
|
0.54
x
|
0.53
x
|
0.39
x
|
0.35
x
|
EV / Revenue
|
0.65
x
|
0.71
x
|
0.86
x
|
0.58
x
|
0.53
x
|
0.52
x
|
0.35
x
|
EV / EBITDA
|
6.69
x
|
6.67
x
|
5.67
x
|
3.67
x
|
5.26
x
|
6.04
x
|
2.58
x
|
EV / FCF
|
-28.3
x
|
-
|
8.94
x
|
6.15
x
|
79.4
x
|
-18.4
x
|
2.17
x
|
FCF Yield
|
-3.53%
|
-
|
11.2%
|
16.3%
|
1.26%
|
-5.42%
|
46%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
27,912
|
28,030
|
28,132
|
27,567
|
26,954
|
26,814
|
-
|
Reference price
2 |
19.96
|
19.99
|
47.25
|
38.02
|
29.96
|
22.13
|
22.13
|
Announcement Date
|
2/21/20
|
2/19/21
|
2/18/22
|
2/17/23
|
2/16/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,297
|
1,158
|
1,685
|
1,946
|
1,534
|
1,539
|
1,695
|
EBITDA
1 |
126.6
|
123.7
|
255.5
|
308.5
|
153.6
|
132.5
|
230.4
|
EBIT
1 |
60.1
|
62.88
|
191.1
|
226.7
|
69.55
|
48.5
|
149.8
|
Operating Margin
|
4.63%
|
5.43%
|
11.35%
|
11.65%
|
4.54%
|
3.15%
|
8.84%
|
Earnings before Tax (EBT)
1 |
53.35
|
55.03
|
185.1
|
225.8
|
69.22
|
37.7
|
141
|
Net income
1 |
41.35
|
46.08
|
139.8
|
171.9
|
54.62
|
28.7
|
107.1
|
Net margin
|
3.19%
|
3.98%
|
8.3%
|
8.83%
|
3.56%
|
1.86%
|
6.32%
|
EPS
2 |
1.430
|
1.640
|
4.810
|
5.920
|
1.950
|
1.090
|
4.110
|
Free Cash Flow
1 |
-29.94
|
-
|
162
|
184.2
|
10.17
|
-43.4
|
273
|
FCF margin
|
-2.31%
|
-
|
9.62%
|
9.46%
|
0.66%
|
-2.82%
|
16.11%
|
FCF Conversion (EBITDA)
|
-
|
-
|
63.43%
|
59.7%
|
6.62%
|
-
|
118.51%
|
FCF Conversion (Net income)
|
-
|
-
|
115.91%
|
107.14%
|
18.62%
|
-
|
254.9%
|
Dividend per Share
2 |
-
|
-
|
-
|
0.5600
|
-
|
0.6400
|
-
|
Announcement Date
|
2/21/20
|
2/19/21
|
2/18/22
|
2/17/23
|
2/16/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
446.5
|
424.1
|
479.1
|
583.7
|
478.8
|
404.1
|
400.5
|
427.9
|
322.9
|
382.2
|
336.8
|
414.2
|
371.4
|
409.7
|
415.6
|
EBITDA
1 |
75.19
|
49.29
|
103.2
|
105.4
|
33.31
|
66.58
|
65.35
|
65.78
|
7.321
|
15.1
|
0.595
|
52.1
|
25
|
54.55
|
61.55
|
EBIT
1 |
59.19
|
33.65
|
82.22
|
86.06
|
12.05
|
46.4
|
45.39
|
43.91
|
-13.46
|
-6.287
|
-20.63
|
33.7
|
1.8
|
30.1
|
39.2
|
Operating Margin
|
13.26%
|
7.94%
|
17.16%
|
14.74%
|
2.52%
|
11.48%
|
11.33%
|
10.26%
|
-4.17%
|
-1.64%
|
-6.12%
|
8.14%
|
0.48%
|
7.35%
|
9.43%
|
Earnings before Tax (EBT)
1 |
57.69
|
32.08
|
82.26
|
85.12
|
12.76
|
45.65
|
44.23
|
43.28
|
-10.05
|
-8.236
|
-23.42
|
31
|
-0.9
|
27.4
|
37
|
Net income
1 |
43.94
|
23.59
|
63.07
|
65.16
|
10.03
|
33.62
|
34.95
|
32.73
|
-7.977
|
-5.082
|
-17.4
|
23.6
|
-0.7
|
20.8
|
28.1
|
Net margin
|
9.84%
|
5.56%
|
13.17%
|
11.16%
|
2.1%
|
8.32%
|
8.73%
|
7.65%
|
-2.47%
|
-1.33%
|
-5.16%
|
5.7%
|
-0.19%
|
5.08%
|
6.76%
|
EPS
2 |
1.510
|
0.8000
|
2.150
|
2.230
|
0.3500
|
1.180
|
1.220
|
1.160
|
-0.2900
|
-0.1900
|
-0.6500
|
0.8900
|
-0.0300
|
0.7900
|
1.070
|
Dividend per Share
2 |
-
|
-
|
0.1250
|
0.1450
|
0.1450
|
0.1450
|
0.1450
|
0.1600
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/29/21
|
2/18/22
|
5/6/22
|
8/5/22
|
11/4/22
|
2/17/23
|
5/5/23
|
8/4/23
|
11/3/23
|
2/16/24
|
5/3/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
290
|
264
|
120
|
84
|
-
|
207
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.289
x
|
2.138
x
|
0.4693
x
|
0.2724
x
|
-
|
1.562
x
|
-
|
Free Cash Flow
1 |
-29.9
|
-
|
162
|
184
|
10.2
|
-43.4
|
273
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
4.170
|
3.970
|
7.530
|
9.420
|
4.200
|
3.820
|
15.10
|
Capex
1 |
150
|
82.9
|
56.8
|
89.4
|
107
|
143
|
110
|
Capex / Sales
|
11.59%
|
7.16%
|
3.37%
|
4.6%
|
7%
|
9.26%
|
6.49%
|
Announcement Date
|
2/21/20
|
2/19/21
|
2/18/22
|
2/17/23
|
2/16/24
|
-
|
-
|
Last Close Price
22.13
USD Average target price
38.33
USD Spread / Average Target +73.22% Consensus |
1st Jan change
|
Capi.
|
---|
| -26.13% | 690M | | +14.70% | 64.83B | | -1.61% | 46.29B | | +14.58% | 40.05B | | +20.84% | 26.72B | | +1.16% | 17.45B | | -21.87% | 15.82B | | +1.11% | 15.02B | | -11.34% | 14.73B | | -20.82% | 13.34B |
Other Specialty Chemicals
|